logo-loader
viewOncimmune

Oncimmune Hldngs PLC - Holdings in Company

RNS Number : 1879P
Oncimmune Holdings PLC
08 June 2020
 

Oncimmune Holdings plc

 

("Oncimmune" or the "Company")

 

Holdings in Company

 

Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, announces that on 5 June 2020 it received a Notification of Major Holdings in shares as set out below.

 

To enable him to focus on other activities, Mr Sharp stepped down as a non-executive Director of the Company on 4 May 2020.

 

On 4 June 2020, Mr Sharp transferred his entire holding of 4,280,749 ordinary shares of 1p in the Company ("Shares") into a blind trust ("Trust") of which he remains the sole beneficiary (as set out in the first TR-1 below) but over which he has no control.

 

In addition, on the same day, the Trust acquired, at the direction of the trustee, a further 166,251 Shares, increasing  its holding in the Company to 4,447,000 Shares equal to 7% of the total issued share capital (as set out in the second  TR-1 below).

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oncimmune Holdings PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify): Transfer of Shares


3. Details of person subject to the notification obligation

Name

Richard Sharp

City and country of registered office (if applicable)


4. Full name of shareholder(s) (if different from 3.)

Name

Blind Trust (Richard Sharp)

City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:

04/06/2020

6. Date on which issuer notified (DD/MM/YYYY):

05/06/2020

7. Total positions of person(s) subject to the notification obligation


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

6.7%


6.7%

63,500,047

Position of previous notification (if

applicable)





 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

X

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
(please add additional rows as necessary)


Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold






















10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held



11. Additional information

Richard Sharp's shares transferred to a Blind Trust of which he is the sole beneficiary and over which he has no control.

 

Place of completion

London, United Kingdom

 

Date of completion

04-Jun-2020

 

 



 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oncimmune Holdings PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify):


3. Details of person subject to the notification obligation

Name

Richard Sharp

City and country of registered office (if applicable)


4. Full name of shareholder(s) (if different from 3.)

Name

Blind Trust (Richard Sharp)

City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:

04/06/2020

6. Date on which issuer notified (DD/MM/YYYY):

05/06/2020

7. Total positions of person(s) subject to the notification obligation


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

7%


7%

63,500,047

Position of previous notification (if

applicable)

6.7%


6.7%


 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

X

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
(please add additional rows as necessary)


Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold






















10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held



11. Additional information

The Blind Trust (Richard Sharp), under the direction of the trustee, purchased 166,251 additional shares on 04/06/2020

 

 

Place of completion

London, United Kingdom

 

Date of completion

04-Jun-2020

 

 

 

For further information:

 

Oncimmune Holdings plc

Ron Kirschner, General Counsel and Company Secretary

[email protected]  


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
HOLEAFKXELPEEAA

Quick facts: Oncimmune

Price: 145.05

Market: AIM
Market Cap: £92.13 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Oncimmune CEO says they're seeing 'significant interest' in its EarlyCDT...

Oncimmune Holdings PLC's (LON:ONC) Adam Hill tells Proactive the next 18 months are expected to create substantial revenues within the EarlyCDT lung cancer test business while the pipeline of contracts within the ImmunoINSIGHTS services business is building. In a trading update covering the...

on 5/6/20